Asarina Pharma AB (publ) (ASAP.ST)
SEK 0.03
(-31.03%)
SEK 0.03
(-31.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Assets | 6.07 Million | 16.85 Million | 30.36 Million | 68.28 Million | 139.89 Million | 149.58 Million |
| Total Current Assets | 5.29 Million | 15.67 Million | 28.88 Million | 66.45 Million | 138.12 Million | 149.57 Million |
| Cash And Short Term Investments | 3.16 Million | 13.57 Million | 21.71 Million | 58.5 Million | 129.5 Million | 141.54 Million |
| Cash and Cash Equivalents | 3.16 Million | 13.57 Million | 21.71 Million | 58.5 Million | 129.5 Million | 141.54 Million |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | 2.13 Million | 2.05 Million | 7.16 Million | 7.95 Million | 8.62 Million | 8.03 Million |
| Inventory | - | 1.00 | -7168.00 | -7951.00 | -8620.00 | -8.03 Million |
| Other Current Assets | -1000.00 | 44 Thousand | 7168.00 | 7951.00 | 8620.00 | 8.03 Million |
| Total Non-Current Assets | 780 Thousand | 1.18 Million | 1.47 Million | 1.83 Million | 1.76 Million | 1000.00 |
| Net PPE | 778 Thousand | 1.18 Million | 1.47 Million | 1.83 Million | 1.76 Million | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | 1000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 1000.00 | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 4.42 Million | 2.25 Million | 9.21 Million | 15.68 Million | 20.42 Million | 9.67 Million |
| Total Current Liabilities | 4.42 Million | 2.25 Million | 9.21 Million | 15.68 Million | 20.42 Million | 9.67 Million |
| Account Payables | 626 Thousand | 837 Thousand | 2.15 Million | 11.3 Million | 16.6 Million | 5.6 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 1 Million | - | 5.3 Million | - | - | - |
| Deferred Revenue | - | - | 1.3 Million | - | - | - |
| Other Current Liabilities | 2.8 Million | 1.41 Million | 462 Thousand | 4.37 Million | 3.81 Million | 4.06 Million |
| Total Non Current Liabilities | 2000.00 | -1000.00 | - | - | - | - |
| Long-Term Debt | 1 Million | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | -998 Thousand | -1000.00 | - | - | - | - |
| Other Liabilities | -2000.00 | - | - | - | - | - |
| Total Equity | 1.64 Million | 14.6 Million | 21.14 Million | 52.59 Million | 119.47 Million | 139.91 Million |
| Stock Holders Equity | 1.64 Million | 14.6 Million | 21.14 Million | 52.59 Million | 119.47 Million | 139.91 Million |
| Common Stock | 5.66 Million | 5.66 Million | 4.68 Million | 4.68 Million | 4.61 Million | 4 Million |
| Retained Earnings | -281.69 Million | -268.74 Million | -256.35 Million | -224.9 Million | -149.64 Thousand | - |
| Accumulated other comprehensive income | 1000.00 | 1.00 | - | - | -149.64 Million | -77.98 Million |
| Common Stock Equity | 1.64 Million | 14.6 Million | 21.14 Million | 52.59 Million | 119.47 Million | 139.91 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | 1000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 |
| Total Debt | 1 Million | - | 5.3 Million | - | - | - |
| Net Debt | -2.16 Million | -13.57 Million | -16.41 Million | -58.5 Million | -129.5 Million | -141.54 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Total Assets | 6.07 Million | 6.07 Million | 6.07 Million | 7.9 Million | 7.9 Million | 16.85 Million |
| Total Current Assets | 5.29 Million | 5.29 Million | 5.29 Million | 6.87 Million | 6.87 Million | 15.67 Million |
| Cash And Short Term Investments | 3.16 Million | 3.16 Million | 3.16 Million | 4.72 Million | 4.72 Million | 13.57 Million |
| Cash and Cash Equivalents | 3.16 Million | 3.16 Million | 3.16 Million | 4.72 Million | 4.72 Million | 13.57 Million |
| Short Term Investments | - | - | - | 999.00 | - | - |
| Net Receivables | 2.13 Million | - | - | - | - | 2.05 Million |
| Inventory | - | - | - | - | - | 1.00 |
| Other Current Assets | -1000.00 | -1000.00 | 2.13 Million | -1000.00 | 2.14 Million | 44 Thousand |
| Total Non-Current Assets | 780 Thousand | 779 Thousand | 780 Thousand | 1.02 Million | 1.02 Million | 1.18 Million |
| Net PPE | 778 Thousand | 778 Thousand | 778 Thousand | 1.02 Million | 1.02 Million | 1.18 Million |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | 1000.00 | 1000.00 | 1000.00 | 1.00 | 1000.00 | 1000.00 |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 1000.00 | - | 1000.00 | 999.00 | 1000.00 | - |
| Other Assets | - | 1000.00 | - | 1000.00 | - | - |
| Total Liabilities | 4.42 Million | 4.42 Million | 4.42 Million | 2.48 Million | 2.48 Million | 2.25 Million |
| Total Current Liabilities | 4.42 Million | 4.42 Million | 4.42 Million | 2.48 Million | 2.48 Million | 2.25 Million |
| Account Payables | 626 Thousand | 626 Thousand | 626 Thousand | 1.1 Million | 1.1 Million | 837 Thousand |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 1 Million | 1 Million | 1 Million | - | - | - |
| Deferred Revenue | - | 2.8 Million | - | - | - | - |
| Other Current Liabilities | 2.8 Million | -2000.00 | 2.8 Million | 1.37 Million | 1.37 Million | 1.41 Million |
| Total Non Current Liabilities | 2000.00 | 2000.00 | 999 Thousand | 1000.00 | - | -1000.00 |
| Long-Term Debt | 1 Million | 1 Million | 1 Million | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | -998 Thousand | -998 Thousand | -1000.00 | 1000.00 | - | -1000.00 |
| Other Liabilities | -2000.00 | - | -999 Thousand | - | - | - |
| Total Equity | 1.64 Million | 1.64 Million | 1.64 Million | 5.42 Million | 5.42 Million | 14.6 Million |
| Stock Holders Equity | 1.64 Million | 1.64 Million | 1.64 Million | 5.42 Million | 5.42 Million | 14.6 Million |
| Common Stock | 5.66 Million | 5.66 Million | 5.66 Million | 5.66 Million | 5.66 Million | 5.66 Million |
| Retained Earnings | -281.69 Million | -281.69 Million | -281.69 Million | -278.28 Million | -277.91 Million | -268.74 Million |
| Accumulated other comprehensive income | 1000.00 | 1000.00 | 1000.00 | 1.00 | 1000.00 | 1.00 |
| Common Stock Equity | 1.64 Million | 1.64 Million | 1.64 Million | 5.42 Million | 5.42 Million | 14.6 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | 1000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 | 1000.00 |
| Total Debt | 1 Million | 1 Million | 1 Million | - | - | - |
| Net Debt | -2.16 Million | -2.16 Million | -2.16 Million | -4.72 Million | -4.72 Million | -13.57 Million |
EPBIO
API
688113
301004
DAVA
322000